Stocks To Buy Now Blog

All posts by Christopher

SPYR Inc. (SPYR) Appoints Michael Teitelbaum and Siobhán Ellis to Subsidiary Applied Magix Inc. Advisory Board

SPYR Inc. (SPYR) Appoints Michael Teitelbaum and Siobhán Ellis to Subsidiary Applied Magix Inc. Advisory Board
  • Both additions to the advisory board will aid SPYR’s continued effort to identify and target acquisitions to grow in the industry and expand its product offering to consumers
  • Mr. Teitelbaum’s experience as the senior board integrity manager of Jazzwares will help him leverage the resources necessary to facilitate growth and grow the brand
  • Ms. Ellis is an avid HomeKit user and has experience working with data in her current role at the U.K. offices of Jaguar Land Rover
Technology company SPYR (OTCQB: SPYR), dba SPYR Technologies, and its subsidiary Applied Magix Inc., which develops and resells Apple(R) compatible products for the multibillion-dollar IoT (internet of things) smart home and car markets, has announced two recent additions to the company’s advisory board — Michael Teitelbaum and Siobhán Ellis. The two additions will aid in SPYR’s continued effort to identify and target acquisitions to grow its footprint in the industry and expand its product offering to consumers, including companies developing artificial intelligence (“AI”) and smart technology products. Applied Magix’s CEO, Dr. Harald Zink, spoke on both of these additions to the company’s advisory board. “I’m genuinely excited to have Mike on our advisory board, offering us his expertise and experience. Mike’s experience in growing brands and creating growth by leveraging online resources will be invaluable on our Applied Magix journey,” Dr. Zink said (https://ibn.fm/5jEqu). Mr. Teitelbaum is the senior brand integrity manager at Jazzwares. He stated that he was beyond excited to join the advisory board of Applied Magix. “I welcome the opportunity to share my expertise and experience and guide Applied Magix to new heights!” About Ms. Ellis’s appointment, Dr. Zink said it was a great pleasure to see her on the board (https://ibn.fm/PriUg). “Siobhán has been a great help by sharing her HomeKit experience and technical insights ever since she reached out to us when our website first went live. … Siobhán will be essential as we reach out to more online influencers and look to merge and acquire more resources under the Applied Magix banner.” Ms. Ellis lives in the U.K. and utilizes HomeKit products to make her home smarter, which presents challenges as her home was built in the 1850s. She currently works in the data office for Jaguar Land Rover in the U.K. “There are so few companies out there who concentrate on Apple’s HomeKit ecosystem, and too many that end up diluting their offering to be compliant with other platforms. I particularly appreciate that as I have made my own homes smart in the last few years, both in California and now the U.K.,” Ellis said. “This experience led me to write my own blog, on that continuing journey to help others who are just starting out. I am convinced that Applied Magix has the vision to bring products to market that solve some of the difficult aspects of home automation, without compromise.” SPYR CEO Tim Matula also commented on Ms. Ellis’ appointment to the board, saying that her diverse background and focused experience complements the company’s philosophy. “Everyone here at SPYR is working as part of a cohesive team towards the same goal — building a better SPYR and bringing the best products and services to our customers.” For product information, please see the Applied Magix website at https://AppliedMagix.com or specific product sites: For more information about SPYR, visit the company’s website at www.SPYR.com. NOTE TO INVESTORS: The latest news and updates relating to SPYR are available in the company’s newsroom at https://ibn.fm/SPYR

SRAX Inc. (NASDAQ: SRAX) Seeks to Become the Information Venue of Choice for Today’s Retail Investor Community

  • Retail investment has boomed of late, with retail investors accounting for 23% of all U.S. equity market transactions in 2021
  • SRAX and investor intelligence platform, Sequire, have sought to service the informational needs of a burgeoning investor community, which now numbers over 9 million
  • Sequire has looked to add value through a series of investor masterclasses and a community investor newsletter, as well as an array of corporate access events focusing on all segments of the stock market
  • SRAX and Sequire sought to bolster their investment offering through the acquisition of leading small and mid-cap stock specialist, LD Micro, in late 2020
At multiple times during 2021, retail investors made up a third of all U.S. stock market trading. In fact, over the past year, retail investors in the United States have on average accounted for 23% of all U.S. equity trading – more than twice the level of 2019. Effectively, that means that retail investors now possess a stock market footprint which is approximately as large as all hedge funds and mutual funds combined (https://ibn.fm/6XWyz). Meanwhile, a survey carried out by Deutsche Bank found that nearly half of those investors were venturing into the stock market for the first time. The rise of the North American retail investor base has led to a greater desire for financial information – a need which financial technology company SRAX (NASDAQ: SRAX) has sought to fulfil. During the late 1990s, a prior period marked by retail investor enthusiasm which would ultimately culminate with the dotcom boom and bust, a study carried out by Oklahoma State and Emory University found that the average retail investor was 50 years old and had around $47 thousand to play with. In contrast, today’s average investor is around 31 years old, has between $1,000 and $5,000 to invest, and is likely to be a member of an online retail investor chat forum. In fact, one particularly influential Reddit-based group currently boasts upwards of 9.4 million members, a figure which has swelled ten times over since the start of 2020. SRAX, and its investor intelligence platform, Sequire, have looked to cater to the rapidly rising population of retail, high-net-worth, and institutional investors, and their need for financial information and interaction amongst their peers. Since its inception, Sequire has seen its community swell to over nine million influential, forward-thinking investors and shareholders, firmly establishing itself as a venue where investors can congregate to learn, share and network on a wide range of industry related topics. Ranging from curating educational opportunities with leading investors and industry experts through masterclasses, to publishing a community newsletter to provide members with relevant and timely stock market and industry updates and hosting a wide array of virtual and in-person investor conferences every year, Sequire has taken it upon themselves to help their followers stay in the know and make informed investing decisions. That mission was further reinforced in late 2020, when SRAX acquired LD Micro, one of the leading data and event companies servicing the small and micro-space. Having hosted over 1,500 companies within their well-established industry events since 2008, SRAX and Sequire have sought to make LD Micro’s must-attend events the centrepiece of their conference offering; the success of that initiative was self-evident over the course of the 2021 LD Micro Main Event, which marked the first in-person conference for LD Micro in nearly two years following the onset of the pandemic. Held between October 12-14, 2021, the LD Micro Main Event attracted 139 companies in a dual, in-person and virtual format (https://ibn.fm/iILse). A recent survey carried out by Accenture revealed that 55% of wealth management consumers in the U.S. and Canada found that the financial advice they received was too generic, with 34% of all investors stating that they would increase their investments if they received a more personalized experience (https://ibn.fm/CCJd5). SRAX has increasingly sought to fulfil that role for its millions of followers, providing a vast legion of investment services, newsletters and corporate access events designed to satisfy the needs of an increasingly discerning – and active – investment community. For more information, visit the company’s website at www.SRAX.com. NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

DGE’s 2nd Risk-Based Quality Management Summit to Enhance Skills for Successful Risk-Based Monitoring of Clinical Trials

On April 4-5, 2022, biopharma and medical device professionals responsible for clinical operations, data management and risk evaluation are invited to attend the live streaming of the 2nd Risk-Based Quality Management Summit. The event is organized by Dynamic Global Events (“DGE”), an educational conference company specializing in the informational and networking needs of the life science sector. The 2-day event will start with the chairperson’s opening remarks followed by keynotes on a structured change management program for RBQM success. For successful risk-based monitoring and effective implementation of clinical trials, a world-class end-to-end comprehensive risk management plan is essential. The agenda goes into extensive detail on this topic. Experts will discuss the effective methods to convince and educate shareholders on the importance of complete buy-in across the organization. They will further talk about the importance of regulatory acceptance of remote monitoring and digital technologies, and also share their expertise on how to comfortably maintain levels of risk tolerance and agility in complex clinical trials while accelerating drug development. This summit covers new approaches in mitigating risk and managing challenges to clinical trial oversight. The RBQM Summit provides up-to-date strategies on reducing the complexity and costs associated with clinical trials, cutting down the risks involved, and deriving the maximum output from the R&D budget. Companies and professionals will learn how to evaluate risks in virtual trials, understand the complexities involved, and thereafter construct a strong framework for their clinical trials. Industry leaders with robust experience will share insights on K-97-1 and the FDA’s “Decision Tree”. Attendees will also learn the spotlight benefits of AI and ML for curating unstructured data. They can leverage this platform to explore data literacy as the change agent to deliver study wide insights, and learn to plan and implement QTLs for ICH E6 (“R2”) compliance. Despite all measures, why do clinical trials fail? Join the valuable sessions at the 2nd Risk-Based Quality Management Summit to understand why studies fail and build strategies to improve trial success. To learn more, please visit https://ibn.fm/TSqRE

Interactive Session on Psychedelics for Alcoholism, Q&A with Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) Management

Clearmind (CSE: CMND) (FSE: CWY0) Management invites leaders, innovators, scientists, doctors, patients, enthusiasts, and luminaries in the psychedelic space to attend a virtual Q&A session on March 30th, focused on the potential treatment of alcohol use and binge drinking based on its psychoactive molecule MEAI. Global leaders and innovators in the psychedelic space will participate in the virtual event and discuss psychedelic therapies and treatments for excessive alcohol consumption and mental disorders. The dedicated team of experts at Clearmind is engaged in developing breakthrough treatments for binge behaviour, alcohol use disorder, binge eating and depression. Adi Zuloff-Shani, PhD, Clearmind’s Chief Executive Officer, is one of the leading speakers at the event, with over 20 years of strategic and operational leadership in the health care industry and in-depth knowledge on therapeutics development in heavily regulated environments. In addition, Shannon Smadella, Clearmind’s Community Development, will host the Q&A sessions. She has interviewed numerous innovators, doctors and luminaries in the health and wellness space. Adjunct Prof. Mark Haden, Clearmind’s VP of Business Development, is also one of the speakers at the Clearmind Mangement event. Mark has published on the issue of drug control policy and psychedelics and has significant contribution in counselling, supervisory and management of addiction. Previously, people needing care for alcohol use disorders had only a limited range of options. At the Clearmind Management Psychedelics for Alcoholism session, influential personas and leading doctors, scientists, and professors of the psychedelic space will discuss the drug control policies, as well as offer counselling and advice on addiction, binge eating and depression. The agenda of the event is to create awareness about the potential treatment for alcohol use disorder, psychedelics and other therapies, and make them more acceptable. This event will offer a robust platform for discussions among renowned leaders about the psychedelic treatment options for binge drinking, and further, how these medicines enhance the mental state. The Clearmind Management panel will answer queries on alcohol use disorder, and eminent industry thinkers who have spent years researching the phenomenal uses of psychedelic compounds will offer their valuable opinions about the treatment of alcohol use disorder using its psychoactive molecule MEAI. Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0), (“Clearmind” or the “Company“), a psychedelic medicine biotech company engaged in the discovery and development of novel psychedelic-derived therapeutics, recently announced its entry into a development and supply agreement with Aragen Life Sciences Pvt. Ltd (“Aragen”) for the production of its innovative molecule, 5-Methoxy-2-aminoindane (“MEAI”) (https://ibn.fm/WkwwD). For more information, please visit https://ibn.fm/BLHsB

Delic Holdings Corp (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Makes Psychedelic Treatment More Accessible with Opening of New Reno Clinic

  • Following the acquisition of KWC back in November 2021, Delic Holdings Corp set out to open additional state-of-the-art ketamine infusion treatment clinics over the course of 18 months
  • The company has just announced the opening of its second clinic in Nevada in a move that will serve both local patients and those in larger California markets without access to affordable in-state providers
  • Delic is still set to open more clinics over the course of the next 18 months in a move that seeks to expand access to reasonably priced treatments for various mental health conditions
In November 2021, Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) announced the completed acquisition of Ketamine Wellness Centers Arizona LLC (“KWC”). This transaction would bring Delic’s consolidated revenue run rate to $11 million. In addition, and more importantly, it would earn it the title of the largest chain of wellness centers providing ketamine treatments in the United States (https://ibn.fm/AQOU5). Following the acquisition, Delic set out to open additional state-of-the-art ketamine infusion treatment clinics over 18 months in a move that would expand access to millions of people who can benefit from new medicines and treatments for various mental health conditions. In what marks a significant milestone for the company, it has opened its second clinic in Nevada, bringing the total number of KWC clinics to 13 across nine states (https://ibn.fm/VJXKL). The new Reno location features a 2,200 square-foot treatment facility, fully equipped to serve both local patients and those in larger California markets who do not have access to affordable in-state providers. Delic is confident that this new location and the others to come over the next 18 months will expand access to reasonably priced treatments for various mental health conditions. “KWC Reno expands our footprint to serve so many more individuals suffering from treatment-resistant anxiety, depression and PTSD to further combat the country’s on-going mental health crisis,” noted Kevin Nicholson, KWC’s Chief Executive Officer (“CEO”) and Delic’s Chief Operating Officer (“COO”). “We look forward to providing the most effective and personalized treatments to patients in both Nevada and California,” he added (https://ibn.fm/VJXKL). This move by Delic complements the company’s overall goal of scaling the impact and reach of treatment. So far, the company’s standing is defined by its umbrella of businesses that form an ecosystem. These include the largest and most accessible network of physical clinics, a licensed lab for R&D and innovation, trusted media, e-commerce platforms, and in-person events that market services directly to patients and consumers. For more information, visit the company’s website at www.DelicCorp.com. NOTE TO INVESTORS: The latest news and updates relating to DELCF are available in the company’s newsroom at https://ibn.fm/DELCF

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Focusing on Profitability and Growth of Its Verticals in 2022

  • PlantX is the digital face of the plant-based community whose verticals operate across three main categories: products, distribution and community
  • The company is leveraging a robust e-commerce ecosystem to link consumers to over 5,000 plant-based products
  • By opening new locations for its XMarket brick and mortar stores, the company has strengthened its distribution capabilities
  • PlantX also offers educational resources as well as fitness solutions
  • Moving forward, the company has locked its sights on profitability, building on the growth witnessed in its most recent quarter
Created as a plant-based lifestyle brand, PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) has always targeted the enrichment of people’s lives through plant-based education and promoting general health, wellness and fitness, a goal that informed its adoption of a three-pronged, all-encompassing operational approach. Through its numerous verticals — whose operations are segmented into three main categories: products, distribution and community – the company has created a platform that has effectively become the one-stop shop for everything plant-based. Under the products category, PlantX offers more than 5,000 plant-based products from different brands, both new and established, through a powerful e-commerce ecosystem encompassing disparate online shopping platforms, including Little West, Bloombox Club and PlantX. In addition, PlantX offers its complete product catalog on various other online marketplaces, including Walmart Canada, the Canadian Subsidiary of Walmart Inc. (NYSE: WMT), Amazon.com (NASDAQ: AMZN), and Hudson’s Bay (The Bay Marketplace). But e-commerce would not be successful without distribution, which is why PlantX has invested in infrastructure that not only facilitates distribution but also acts as the company’s face, away from the virtuality of the digital world. Part of this infrastructure is branded XMarket, the company’s brick and mortar stores located in high-traffic epicenters of plant-based communities. So far, PlantX has opened XMarket stores in Venice Beach (Los Angeles), Squamish, San Diego, Chicago Uptown, Yorkdale, Rideau, and Tel Aviv, with plans to open additional stores under a franchising model, according to company president and CEO Lorne Rapkin (https://ibn.fm/WkAH0). PlantX has also dedicated resources toward building a community, most recently adding a new fitness vertical — XFitness. XFitness is an online fitness service that will offer members access to a wide selection of live and on-demand fitness classes delivered by pre-selected professional instructors. At the same time, PlantX has sought to consistently create awareness about plant-based lifestyles, delicious recipes and products through videos published on its YouTube channel (https://www.youtube.com/c/PlantX) as well as educative blog posts uploaded on its websites. Collectively, these verticals have immensely contributed to the company’s growth over the past year. In the three months ended Dec. 31, 2021, for example, PlantX reported gross revenue of CA$2.74 million, representing a year-over-year increase of CA$907,935 compared to the three months ended Dec. 31, 2020 (https://ibn.fm/Xg8WM). Motivated by this growth, the company is committed to extending the positive trajectory even further. Having generated more than CA$5.4 million in gross proceeds from the completion of a recent private placement, PlantX intends to funnel the funds into business development, working capital and general corporate purposes (https://ibn.fm/IA4Wi). “The goal right now is to take the verticals we currently have and build them out into more profit centers, and we just needed a little bit more of a runway, and this raise certainly helps us get to that point,” Rapkin said of the benefits the proceeds will have on the company’s operations (https://ibn.fm/mhe6m). “Where we are going into in 2022 is the growth mode. We’ve expanded a lot of our platforms into different parts of the world, and we’re really harnessing the profitability of our verticals. And that’s why we’ve spent the past 90 days restructuring a lot of the verticals to become more profitable,” continued Rapkin. PlantX also aims to continue providing its products to more participants, customers and countries, while at the same time building on the lifestyle platform it has set out to offer the plant-based community and people interested in the plant-based lifestyle. For more information, visit the company’s website at www.PlantX.com, www.PlantX.ca, and https://investor.plantx.com and view PlantX for Plant-Based Investors. NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Is a Leader in Psychedelic-Based Therapies; Recent Preclinical Research Shows Treatment Effective for MDD

  • Study shows that substantial antidepressant effects of psilocybin-based treatment, given with supportive psychotherapy, may last at least a year.
  • Psilocybin could lead to significant, durable improvements in depression.
  • Cybin is focused on improving overall mental health through psychedelic-based therapies.
Johns Hopkins Medicine researchers have released a report noting that psilocybin treatment for major depression is effective for up to a year for many patients (https://ibn.fm/ZF8jH). That bodes well for Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company that is focused on revolutionizing mental health care, including major depressive disorder (“MDD”). “Previous studies by Johns Hopkins Medicine researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month,” stated the report, which was published last month in the “Journal of Psychopharmacology.” The article went on to note that “in a follow-up study of those participants, the researchers report that the substantial antidepressant effects of psilocybin-assisted therapy, given with supportive psychotherapy, may last at least a year for some patients.” One of the researchers, Dr. Natalie Gukasyan, an assistant professor of psychiatry and behavioral sciences at Johns Hopkins Medicine, stated, “Our findings add to evidence that, under carefully controlled conditions, this is a promising therapeutic approach that can lead to significant and durable improvements in depression.” She noted that the results are in a research setting and require preparation and structured support from trained clinicians and therapists. “People should not attempt to try it on their own,” Dr. Gukasyan cautioned. The Johns Hopkins article stated that, during the last two decades, a growing number of studies and research efforts focusing on classic psychedelics has been conducted, including work focused on the pharmacological class of compounds that include psilocybin, a natural-occurring psychoactive compound found in so-called magic mushrooms. “Treatment with psilocybin has shown promise in research settings for treating a range of mental health disorders and addictions,” the article noted. The follow-up Johns Hopkins study involved 27 participants (19 women, 8 men) with a long-term history of depression, most of whom had been experiencing depressive symptoms for approximately two years before recruitment; a majority of the participants had been treated with standard antidepressant medications, with 58% currently using antidepressants. The participants were randomly divided into two groups and received treatment either immediately or after an eight-week waiting period. This treatment included preparatory meetings, two doses of psilocybin and follow-up evaluation. According to the article, “The researchers reported that psilocybin treatment in both groups produced large decreases in depression, and that depression severity remained low one, three, six and 12 months after treatment.” The article quoted Dr. Roland Griffiths, who said that “psilocybin not only produces significant and immediate effects, but it also has a long duration, which suggests that it may be a uniquely useful new treatment for depression. Compared to standard antidepressants, which must be taken for long stretches of time, psilocybin has the potential to enduringly relieve the symptoms of depression with one or two treatments.” Griffiths is the Oliver Lee McCabe III, PhD, Professor in the Neuropsychopharmacology of Consciousness at the Johns Hopkins University School of Medicine and founding director of the Johns Hopkins Center for Psychedelic and Consciousness Research. Cybin is focused on becoming a leader in the psychedelic space. The company currently has three active drug programs targeting major depressive disorder, alcohol use disorder, anxiety disorders and neuroinflammation, as well as 50 novel compounds developed with more than 10 patent filings across three patent families (https://ibn.fm/GSwiS). In terms of investor interest, Cybin has raised C$120 million to date to support its clinical trials and M&A strategy. In addition, the company is working with a network of world-class partners and internationally recognized scientists to create safe and effective therapeutics for patients to address a multitude of mental health issues. Headquartered in Canada and founded in 2019, Cybin is operational in the United States, the United Kingdom and Ireland. The company is focused on progressing psychedelics to therapeutics by engineering proprietary drug-discovery platforms, innovative drug-delivery systems, novel formulation approaches and treatment regimens for mental health disorders. For more information, visit the company’s website at www.Cybin.com. NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

Nowigence Inc.’s (NOWG) Pluaris Provides a Real Solution to Data Overload

  • An all-in-one, easy-to-use personal knowledge management platform, Pluaris assists users with automated reading and analysis of textual data.
The sheer volume of information available in the digital realm is unfathomable. Despite these astronomical numbers, many people want to — or are expected to — be on top of the latest and greatest information. A recent “Seed Scientific” report included words such as zettabytes, exabytes and petabytes when talking about data on the internet (https://ibn.fm/ecmNR). While these words may sound almost made up, they are real measurements in today’s data-driven world, measurements that Nowigence Inc. (NOWG) is keenly aware of. “How much data is created every day?” the “Seed Scientific” article asks. “Frankly, there is no definitive answer to this basic question. The Googles, Amazons and Facebooks of the world could not keep count even if they wanted to.” That said, the article provides a glance at some possible numbers:
  • The amount of data in the world was estimated at 44 zettabytes in 2020.
  • By 2025, the amount of data generated each day is expected to reach 463 exabytes globally.
  • Google, Facebook, Microsoft, and Amazon store at least 1,200 petabytes of information.
Here’s another one of those words — quintillion — and another fact: Nowigence notes that 2.5 quintillion bytes of data are created every day (https://ibn.fm/bXJFy). Nowigence has introduced an all-in-one, easy-to-use personal knowledge management platform designed to assist users with automated reading and analysis of textual data. Called Pluaris, the system reads and analyzes articles, documents and other textual data, enabling readers to learn more in less time, uncover hidden insights and stay on top of the information they need to know. Pluaris helps individuals, teams and entire enterprises make sense of massive amounts of textual data, converting them into bite-size nuggets of intelligence in a short span of time. Once Pluaris has done its job, users simply scan their customized newsfeeds to see summaries and extracted intelligence for each item uploaded. They can also view the graphical analysis of the annotations and analyzed content for unbiased importance ranking. In addition, Pluaris assists in drilling down to any level of granularity using filters. Thanks to Pluaris, users discover new connections, topics and insights. Nowigence is committed to helping individuals, teams and enterprises quickly distill knowledge from massive amounts of textual data, both public and private. By integrating state-of-the-art data processing techniques in an intuitive interface at an affordable subscription price, Pluaris puts the power of data science into the hands of consumers. For more information about the company, visit www.Nowigence.com. NOTE TO INVESTORS: The latest news and updates relating to Nowigence are available in the company’s newsroom at https://ibn.fm/NOW

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Committed to Driving Bitcoin Adoption via Lightning Network Offering; Network Tripled Capacity in 2021

  • The Lightning Network provides instant payment transfers/settlement times, scalability, low costs/fees, and works across blockchain with the same cryptographic hash function
  • The Network’s capacity grew from 1,089 BTC to 3,479 BTC in 12 months
  • LQwD’s active public nodes on the Lightning Network include France, England, Singapore, Sweden, Italy, Indonesia, Germany, Ireland, and the U.S. and collectively have a value of 10.21604901 BTC (US$429,153.33) and 183 active channels
In early October 2021, the research division for Arcane Crypto released their predictions on the advancement of the Lightning Network — hypothesizing that by 2030, the number of users could cross the threshold of 700 million worldwide (https://ibn.fm/8dyZB). The foundation of their research is the consistent growth of the network since 2020, with a wallet payment volume that increased by approximately 20% month-over-month during 2021. They also believe that remittance, gaming and streaming use cases will help realize these numbers in the future. The Lightning Network is a “layer 2” payment protocol layered on a blockchain-based cryptocurrency. The Network is decentralized and uses smart contract functionality to enable payments across the entire network of participants. Benefits of using the Lightning Network to initiate payments and transfers using Bitcoin include:
  • Instant payment transfers/settlement times
  • Scalability that offers millions to billions of transactions per second
  • Low cost, low fee option to send/receive payment
  • Works across blockchain as long as both support the same cryptographic hash function
Despite the recent Bitcoin market fluctuations, the number of Bitcoin locked in the Lightning Network has continued to rise in value. In February 2022, the number of Bitcoin locked in the Network had tripled from a year prior — 1,089 BTC to 3,479 BTC, respectively. Considering Bitcoin value, the worth of the Lightning Network at the time of the report stood at around $1.3 billion (https://ibn.fm/xNJJr). LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a financial technology company invested in the adoption of Bitcoin and associated technology, introduced its platform-as-a-service (“PaaS”) in November 2021, offering users the ability to make payments instantly, securely and inexpensively, while leveraging the Lightning Network. Since that time, LQwD has also invested in the Lightning Network, with nine active public nodes on the network. The active nodes include France, England, Singapore, Sweden, Italy, Indonesia, Germany, Ireland, and the U.S. Collectively, the public nodes have a value of 10.21604901 BTC ($429,153.33) and 183 active channels. For more information, visit the Lightning Network Search and Analysis Engine at www.1ML.com. Despite speculation that the Lightning Network has “plateaued,” the current capacity sits at over 3,500 BTC and continues to rise organically. Instead of the intense rise, which tripled numbers in 2021, experts view this current trend as a natural increase in the network. The Lightning Network is currently still recording a 30% annualized growth — when looking at it on a 30-day average (https://ibn.fm/VbNt3). The Lightning Network’s growth reflects a general increasing trend in the global cryptocurrency market. The sector was valued at $826.6 million in 2020 and is expected to grow at a CAGR of 11.1%, resulting in a value of $1.9 billion in 2028 (https://ibn.fm/l6KvZ). The rise in this market can be attributed to distributed ledger technology, rising digital investments in venture capital, and the adoption of cryptocurrency by more countries as legal tender. The adoption of these coins for transactions is also likely to increase in the coming years, facilitating the growth of the market. For more information, visit the company’s website at www.LQwDFinTech.com. NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF

FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Readies On-Site and Scalable Solution for Green Energy, Agriculture, Amid Worsening Global Crises

  • FuelPositive Corp. is a clean energy solutions innovator focused on delivering accessible and affordable alternatives to planet-polluting fuel systems and ammonia production systems, particularly in the ever-important agricultural sector
  • The war in Ukraine has heightened global food security concerns already raised by the COVID-19 pandemic and ongoing planetary climate change, given the amount of food, fertilizer and fuel annually sourced from Ukraine and Russia
  • FuelPositive’s IP promotes local generation of green, nitrogen- and hydrogen-rich ammonia for earth-friendly energy and agricultural needs
  • FuelPositive plans to begin rolling out prototypes of its intellectual property this summer — a portable, modular, environmentally safe system for producing ammonia on site, as well as hydrogen as a byproduct
The war in Ukraine is accelerating international food supply and climate change concerns, and indirectly demonstrating the importance of efforts by companies such as clean energy solutions innovator FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) to establish a more locally reliant, green supply chain for energy resources, food production and sustainable energy storage systems. FuelPositive is developing a fully portable system for producing and storing green, hydrogen-dense anhydrous ammonia, with a potential end-use application for converting the ammonia to hydrogen and a non-polluting combustion process for dealing with any potential emissions. Just as ammonia is an efficient carrier of hydrogen, for green energy, it is also an efficient carrier of nitrogen, a key ingredient for agricultural fertilizer. As a result, agriculture is the primary user of ammonia. The problem comes from the application of traditional ammonia production, which creates large greenhouse gas emissions, not to mention the emissions associated with the transportation of grey ammonia via a complex and unreliable supply chain. FuelPositive’s green ammonia production system allows farmers to economically produce, on site, the amount of ammonia they need, thereby avoiding supply chain dependence and huge cost fluctuations – all with no carbon emissions. Whether they run on hydroelectric power or windmills or solar panels, etc., FuelPositive’s prototype units are being built to produce up to 300 kg/day of green anhydrous ammonia, which is enough to provide fertilizer and fuel to farms that range in size from hundreds to thousands of acres. FuelPositive’s prototype modular systems will begin rolling out in the late summer of 2022. The company’s recent announcement that experienced global agricultural product operations leader Derek  Boudreau has joined FuelPositive as a strategic adviser responsible for agricultural implementation, highlighted the build-up toward commercialization of the company’s IP. Boudreau comes to FuelPositive after more than 27 years with John Deere Company. “(Boudreau’s) vast experience working in sales, management, manufacturing and distribution with agricultural equipment and internal combustion engines, will help ensure FuelPositive makes the best possible decisions related to the broad range of agricultural opportunities presenting themselves to the company every day,” CEO and Board Chair Ian Clifford stated March 8 (https://ibn.fm/I8suP). “He is starting off reviewing our intellectual property and working with farmers to build our understanding of their practices, preferences and requirements. His knowledge will play a critical role as we determine and maximize the impact our on-site green ammonia production systems will have on farms and in other applications as we grow.” A number of observers have been predicting that Russia’s war in Ukraine will have a devastating impact on global food supply, given many nations’ dependence on Ukraine and Russia for grain, fertilizer and fuels. The COVID pandemic and the worsening climate change outlook were already creating alarm in regard to sustainability of these sectors before the war broke out, leading to “a catastrophe on top of a catastrophe,” global fertilizer giant Yara International’s president and CEO, Svein Tore Holsether, told the BBC in a March 7 report. “We were already in a difficult situation before the war… and now it’s additional disruption to the supply chains and we’re getting close to the most important part of this season for the Northern hemisphere, where a lot of fertilizer needs to move on and that will quite likely be impacted,” Holsether stated (https://ibn.fm/lxe84). “Half the world’s population gets food as a result of fertilisers… and if that’s removed from the field for some crops, [the yield] will drop by 50%. For me, it’s not whether we are moving into a global food crisis — it’s how large the crisis will be.” Additionally, the United Nations’ Intergovernmental Panel on Climate Change (“IPCC”) has published several “dire and detailed” reports on pressing global threats posed by the warming climate since the beginning of the year, which highlight the need to reduce carbon emissions and potentially turn to hydrogen or other green fuels on a more accelerated basis. “Any further delay in concerted anticipatory global action will miss a brief and rapidly closing window of opportunity to secure a livable and sustainable future for all,” the most recent report stated (https://ibn.fm/Y1V9l). The IPCC will hold its 56th session online from March 21 to April 1, simultaneously considering line-by-line its Working Group III’s Summary for Policymakers as government representatives meet with the authors of the group’s report titled “Climate Change 2022: Mitigation of Climate Change” (https://ibn.fm/TodhQ). The IPCC anticipates holding a press conference on April 4 in regard to the report and the session’s close. For more information on FuelPositive Corp., visit the company’s website at www.FuelPositive.com. NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF

From Our Blog

Soligenix Inc. (NASDAQ: SNGX) Strengthens Position in CTCL Treatment with HyBryte(TM) FLASH Results

September 24, 2025

Soligenix (NASDAQ: SNGX) is continuing to build momentum in its mission to advance HyBryte(TM), a first-in-class treatment for early-stage cutaneous T-cell lymphoma (“CTCL”). That progress is supported by results from its pivotal FLASH trial and its ongoing FLASH 2 confirmatory study. Together, the studies highlight not only the efficacy of synthetic hypericin activated by safe […]

Rotate your device 90° to view site.